Correlation Between Hepion Pharmaceuticals and Travere Therapeutics
Can any of the company-specific risk be diversified away by investing in both Hepion Pharmaceuticals and Travere Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Hepion Pharmaceuticals and Travere Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Hepion Pharmaceuticals and Travere Therapeutics, you can compare the effects of market volatilities on Hepion Pharmaceuticals and Travere Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Hepion Pharmaceuticals with a short position of Travere Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Hepion Pharmaceuticals and Travere Therapeutics.
Diversification Opportunities for Hepion Pharmaceuticals and Travere Therapeutics
-0.59 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Hepion and Travere is -0.59. Overlapping area represents the amount of risk that can be diversified away by holding Hepion Pharmaceuticals and Travere Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Travere Therapeutics and Hepion Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Hepion Pharmaceuticals are associated (or correlated) with Travere Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Travere Therapeutics has no effect on the direction of Hepion Pharmaceuticals i.e., Hepion Pharmaceuticals and Travere Therapeutics go up and down completely randomly.
Pair Corralation between Hepion Pharmaceuticals and Travere Therapeutics
Given the investment horizon of 90 days Hepion Pharmaceuticals is expected to generate 1.96 times less return on investment than Travere Therapeutics. But when comparing it to its historical volatility, Hepion Pharmaceuticals is 1.08 times less risky than Travere Therapeutics. It trades about 0.06 of its potential returns per unit of risk. Travere Therapeutics is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest 1,757 in Travere Therapeutics on September 2, 2024 and sell it today you would earn a total of 124.00 from holding Travere Therapeutics or generate 7.06% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Hepion Pharmaceuticals vs. Travere Therapeutics
Performance |
| Timeline |
| Hepion Pharmaceuticals |
| Travere Therapeutics |
Hepion Pharmaceuticals and Travere Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Hepion Pharmaceuticals and Travere Therapeutics
The main advantage of trading using opposite Hepion Pharmaceuticals and Travere Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Hepion Pharmaceuticals position performs unexpectedly, Travere Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Travere Therapeutics will offset losses from the drop in Travere Therapeutics' long position.| Hepion Pharmaceuticals vs. Enveric Biosciences | Hepion Pharmaceuticals vs. Elevation Oncology | Hepion Pharmaceuticals vs. Ocean Biomedical | Hepion Pharmaceuticals vs. Zura Bio Limited |
| Travere Therapeutics vs. Tff Pharmaceuticals | Travere Therapeutics vs. Eliem Therapeutics | Travere Therapeutics vs. Inhibrx | Travere Therapeutics vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Other Complementary Tools
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |